Correspondence 0001104659-24-054057 from SELLAS Life Sciences Group, Inc. (SLS)
SELLAS Life Sciences Group, Inc.
Date: April 29, 2024 · CIK: 0001390478 · Accession: 0001104659-24-054057
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-278337
Letter
Via EDGAR United States Securities and Exchange Commission Division of Corporate Finance Registration Statement on Form S-3 Filed March 28, 2024 File No. 333-278337 Acceleration Request
Dear Mr. Edwards,
Pursuant to Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, SELLAS Life Sciences Group, Inc. (the “Registrant”) hereby respectfully requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-278337), so that it may become effective at 5:00 p.m. (Washington, D.C. time) on Wednesday, May 1, 2024, or as soon thereafter as practicable.
Please call Daniel A. Bagliebter, of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (212) 692-6856 with any comments or questions regarding the Registration Statement.
Very truly yours,
SELLAS Life Sciences Group, Inc.
Show Raw Text
CORRESP
1
filename1.htm
SELLAS Life Sciences Group, Inc.
7 Times Square, Suite 2503
New York, New York 10036
April 29, 2024
Via
EDGAR
Chris Edwards
United States Securities and Exchange Commission
Division of Corporate Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: SELLAS Life Sciences Group, Inc.
Registration Statement on Form S-3
Filed March 28, 2024
File No. 333-278337
Acceleration Request
Dear Mr. Edwards,
Pursuant to Rule 461
of Regulation C promulgated under the Securities Act of 1933, as amended, SELLAS Life Sciences Group, Inc. (the “Registrant”)
hereby respectfully requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-278337),
so that it may become effective at 5:00 p.m. (Washington, D.C. time) on Wednesday, May 1, 2024, or as soon thereafter as practicable.
Please call Daniel A. Bagliebter,
of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (212) 692-6856 with any comments or questions regarding
the Registration Statement.
Very truly yours,
SELLAS Life Sciences Group, Inc.
/s/ Angelos M. Stergiou
By:
Angelos M. Stergiou, M.D., Sc.D., h.c.
Its:
President and Chief Executive Officer
cc: Stacy E. Yeung, Esq., SELLAS
Life Sciences Group, Inc.
Daniel A. Bagliebter, Esq., Mintz, Levin,
Cohn, Ferris, Glovsky and Popeo, P.C.